caprylic/capric/succinic triglyceride

Small moleculeexperimental

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
0
Phase 3
1
Phase 4
0

Earliest trial started Mar 1, 2013 (NCT01741194)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ac-1204
  • ac-1204

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02959710Phase 1Nov 1, 2016Celerion, Cerecin
NCT02833012Phase 1Jul 1, 2016Celerion, Cerecin
NCT02747602Phase 1Apr 1, 2016Celerion, Cerecin
NCT01741194Phase 2/Phase 3 (Phase 3)Mar 1, 2013Cerecin
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
CerecinFor profit4422013
CelerionFor profit3012016
2 organizations
Page 1 / 1